In 2012, Lucy spent six weeks in hospital battling septicaemia. After months of consulting with several leading physicians, and trying to get back on her …
Moderna (NASDAQ: MRNA) has caught the market off guard with a significant recovery in recent days – reaching current levels of approximately $27 after hitting a five-year low of $23.15 …
Since April 11, 2025, UnitedHealth Group (NYSE: UNH) has undergone a prolonged and concerning decrease, culminating in a sharp 5.71% drop on May 21, finishing at $302.98. This represents one …
Wall Street analysts have “Buy” ratings on 388 stocks in the S&P 500. That’s over 76% of the index! Thank you, suits, for the curation. No, seriously. We contrarians are …
Merck (NYSE:MRK) stock has experienced a significant 22% decline this year, sharply underperforming the broader S&P 500 index, which is down only 1%. This downturn can be attributed to several …